DalsnaFinance

Steris $STE

Health Care · Health Care Equipment · NYSE/NASDAQ

S&P 500 Russell 1000 Ireland
Create a scorecard
$217.26
-0.51 (-0.23%)
As of Oct 15, 2026, 1:28 AM EDT
Price history
Loading chart…

Steris (STE) is trading down at $217.26 (-0.23%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

Steris revenue & net income history (FY2017–FY2026)

RevenueNet incomeNet margin (right axis, %)
$5.94B$2.97B$0FY2017 revenue: $2.61BFY2017 net income: $110.0M · Net margin 4.2%'17FY2018 revenue: $2.62BFY2018 net income: $290.9M · Net margin 11.1%'18FY2019 revenue: $2.78BFY2019 net income: $303.7M · Net margin 10.9%'19FY2020 revenue: $3.03BFY2020 net income: $407.7M · Net margin 13.5%'20FY2021 revenue: $3.11BFY2021 net income: $397.4M · Net margin 12.8%'21FY2022 revenue: $4.22BFY2022 net income: $243.9M · Net margin 5.8%'22FY2023 revenue: $4.54BFY2023 net income: $107.0M · Net margin 2.4%'23FY2024 revenue: $5.14BFY2024 net income: $378.2M · Net margin 7.4%'24FY2025 revenue: $5.46BFY2025 net income: $614.6M · Net margin 11.3%'25FY2026 revenue: $5.94BFY2026 net income: $782.3M · Net margin 13.2%'260%5%10%15%FY2017 net margin: 4.2%FY2018 net margin: 11.1%FY2019 net margin: 10.9%FY2020 net margin: 13.5%FY2021 net margin: 12.8%FY2022 net margin: 5.8%FY2023 net margin: 2.4%FY2024 net margin: 7.4%FY2025 net margin: 11.3%FY2026 net margin: 13.2%
Steris annual financial statements
FY2017Mar 2017FY2018Mar 2018FY2019Mar 2019FY2020Mar 2020FY2021Mar 2021FY2022Mar 2022FY2023Mar 2023FY2024Mar 2024FY2025Mar 2025FY2026Mar 2026
Income statement
Revenue$2.61B$2.62B$2.78B$3.03B$3.11B$4.22B$4.54B$5.14B$5.46B$5.94B
Growth (year over year)—+0.3%+6.2%+8.9%+2.5%+35.9%+7.4%+13.3%+6.2%+8.7%
Gross profit$1.03B$1.09B$1.17B$1.32B$1.34B$1.88B$1.98B$2.22B$2.40B$2.63B
Gross margin39.3%41.7%42.2%43.6%43.2%44.6%43.7%43.2%44.0%44.2%
Operating income$226.2M$399.9M$411.0M$537.0M$548.4M$477.8M$791.1M$836.1M$866.6M$1.10B
Operating margin8.7%15.3%14.8%17.7%17.6%11.3%17.4%16.3%15.9%18.6%
Net income$110.0M$290.9M$303.7M$407.7M$397.4M$243.9M$107.0M$378.2M$614.6M$782.3M
Net margin4.2%11.1%10.9%13.5%12.8%5.8%2.4%7.4%11.3%13.2%
EPS (diluted)$1.28$3.39$3.55$4.76$4.63$2.48$1.07$3.81$6.20$7.93
Balance sheet
Cash and equivalents$282.9M$201.5M$220.6M$319.6M$220.5M$348.3M$208.4M$207.0M$171.7M$439.6M
Total assets—$5.20B$5.07B$5.44B$6.57B$11.4B$10.8B$11.1B$10.1B$10.7B
Total liabilities—$1.98B$1.89B$2.02B$2.68B$4.88B$4.73B$4.75B$3.53B$3.54B
Long-term debt—$1.32B$1.18B$1.15B$1.65B$2.95B$3.02B$3.12B$1.92B$1.81B
Shareholders' equity$2.81B$3.21B$3.18B$3.41B$3.88B$6.53B$6.08B$6.30B$6.60B$7.18B
Cash flow
Operating cash flow$424.1M$457.6M$539.5M$590.6M$689.6M$684.8M$756.9M$973.3M$1.15B$1.34B
Capital expenditure$172.9M$165.5M$189.7M$214.5M$239.3M$287.6M$362.0M$360.3M$370.1M$369.0M
Free cash flow$251.2M$292.2M$349.8M$376.0M$450.4M$397.2M$395.0M$613.0M$778.0M$972.4M
Dividends paid$93.2M$102.9M$112.5M$123.0M$133.8M$163.2M$183.5M$200.6M$219.9M$241.8M
Share buybacks$97.5M$65.5M$81.5M$51.2M$14.6M$55.8M$308.6M$11.8M$211.3M$235.5M

From Steris's 10-K and 10-Q filings with the SEC; its fiscal year ends in March. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Steris

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.

Source: Wikipedia — Steris

Headquarters
Dublin, Ireland From SEC filings, Oct 2026

Recent News (16)

More Health Care stocks

Browse all companies →